Opinion · 26 Dec 2024
Conference abstractPublished 2018
Innovative strategy for innovative medicines to ensure patients access to medicines and treatments
Government Affairs and Regulatory Policies, Lebanon
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Innovation medicines will require innovative strategy to ensure patient’s access to medicines. There is a need to start shuffling the status quo of what’s needed to make things more legible and accessible to public health. The name of the game is how we can leverage on the current situation to move forward with the approval of these highly expensive medicines and treatments to our patients. We have reached a demanding level of administrative, academic opportunities of diseases and treatments that require a new approach and innovation solutions to ensure the availability of treatments and medicines to communities at affordable prices. Taking into consideration the budget constraints at all levels of stakeholders. Thus, It is a chain of responsibility that starts from the very early phase of product innovation until it reaches the market. How to engage different stakeholders to meet, to discuss the new reality, to leverage on the current services, to partner together in shaping the policies and upgrade the existing systems, to engage NGO’s and patient’s advocacy groups, to be ready and aligned with the upcoming new class of medicines and treatments including vaccines in the coming years. How can we make this happen in the current financial and economic crisis that has hit most of the markets? How can we engage payers, physicians and different stakeholders to work hand in hand to ensure treatment’s availability? How can we leverage on the social responsibilities projects provided by most reputable international pharmaceutical firms? How can we do things differently? Where are we with the digitalization? How can we INNOVATE new ideas? It is our time to lead these changes to make it a better healthy world for next generation. It is time to innovate new approaches.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Forensic Toxicology & Pharmacology.
Commentary · 26 Dec 2024
Predictive Models for Toxicokinetics in Pharmaceuticals
Perspective · 26 Dec 2024
High-Performance Liquid Chromatography in Clinical Toxicology: Enhancing Diagnostic Precision
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Forensic Toxicology & Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hassan Mohamad Bibi”
